Literature DB >> 16502050

Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.

E O Kehinde1, A O Akanji, A Memon, A A Bashir, A S Daar, K A Al-Awadi, T Fatinikun.   

Abstract

INTRODUCTION: Factors responsible for the low incidence of clinical prostate cancer (3-8/100,000 men/year) in the Arab population remain unclear, but may be related to changes in steroid hormone metabolism. We compared the levels of serum conjugated and unconjugated steroids between Arab and Caucasian populations, to determine if these can provide a rational explanation for differences in incidence of prostate cancer between the two populations. PATIENTS/
METHOD: Venous blood samples were obtained from 329 unselected apparently healthy indigenous Arab men (Kuwaitis and Omanis) aged 15-80 years. Samples were also obtained from similar Arab men with newly diagnosed prostate cancer or benign prostatic hyperplasia (BPH). The samples were taken between 8:00 am and 12:00 noon. Serum levels of total testosterone, (TT), sex hormone binding globulin (SHBG), free androgen index (FAI); adrenal C19-steroids, dehydroepiandrosterone sulphate (DHEAS) and androstenedione (ADT) were determined using Immulite kits (Diagnostic Systems Laboratories Inc, Webster Texas, USA). The results obtained in Arab men were compared with those reported for similarly aged Chinese, German and White USA men.
RESULTS: In all four ethnic groups, median TT and FAI declined with age, while SHBG increased with age. However, the mean TT and SHBG was significantly lower (p < 0.01) and the FAI significantly higher in Arab men (p < 0.01) compared to German men only in 21-30 years age group. In the other age groups the levels of TT and SHBG were higher in the Germans but the differences were not statistically significant. In all the racial groups serum levels of DHEAS and ADT reached a peak by about 20 years of life, and then declined progressively. The mean DHEAS in American Caucasians aged 20-29 years was 11.4 micromol/l compared to 6.22 micromol/l in the Arabs (p < 0.001). The mean DHEAS in USA Caucasians aged 70-79 years was 2.5 micromol/l compared to 1.8 micromol/l (p < 0.03) in the Arabs. There was no significant difference in mean serum levels of DHEAS between German and USA men. Similarly, there was no significant difference in the level of the hormones between Arab and Chinese men. Arab men with newly diagnosed prostate cancer had high serum TT, SHBG and DHEAS compared to those without the disease.
CONCLUSIONS: The mean TT and SHBG was significantly lower in Arab men compared to Caucasian men especially in early adulthood. Caucasians have significantly higher serum levels of the precursor androgens DHEAS and ADT especially in early adulthood compared to Arab men. These observations of low circulating androgens and their adrenal precursors in Arab men may partially account for the decreased risk for prostate cancer among Arab men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502050     DOI: 10.1007/s11255-005-3619-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health.

Authors:  L Ellis; H Nyborg
Journal:  Steroids       Date:  1992-02       Impact factor: 2.668

2.  Hormones and prostate cancer: where do we go from here?

Authors:  A W Hsing
Journal:  J Natl Cancer Inst       Date:  1996-08-21       Impact factor: 13.506

Review 3.  Evolving strategies for prostate cancer chemoprevention trials.

Authors:  Ronald Lieberman
Journal:  World J Urol       Date:  2003-04-01       Impact factor: 4.226

4.  Hormonal predictors of prostate cancer: a meta-analysis.

Authors:  T Shaneyfelt; R Husein; G Bubley; C S Mantzoros
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

5.  Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men.

Authors:  S J Winters; A Brufsky; J Weissfeld; D L Trump; M A Dyky; V Hadeed
Journal:  Metabolism       Date:  2001-10       Impact factor: 8.694

6.  Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.

Authors:  A Bélanger; B Candas; A Dupont; L Cusan; P Diamond; J L Gomez; F Labrie
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

7.  Endocrine alterations in the aging male.

Authors:  Martin W Elmlinger; Thomas Dengler; Christoph Weinstock; Werner Kuehnel
Journal:  Clin Chem Lab Med       Date:  2003-07       Impact factor: 3.694

8.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

Authors:  R K Ross; L Bernstein; R A Lobo; H Shimizu; F Z Stanczyk; M C Pike; B E Henderson
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

9.  'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer.

Authors:  M C Pike; M D Krailo; B E Henderson; J T Casagrande; D G Hoel
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

Review 10.  Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA).

Authors:  E G MacEwen; I D Kurzman
Journal:  J Nutr       Date:  1991-11       Impact factor: 4.798

View more
  6 in total

1.  Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities.

Authors:  Louis Calistro Alvarado
Journal:  Ther Adv Urol       Date:  2011-06

2.  Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

Authors:  Nuria Coll Bastus; Lara K Boyd; Xueying Mao; Elzbieta Stankiewicz; Sakunthala C Kudahetti; R Tim D Oliver; Daniel M Berney; Yong-Jie Lu
Journal:  Cancer Res       Date:  2010-10-14       Impact factor: 12.701

3.  Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis.

Authors:  A Richard; S Rohrmann; L Zhang; M Eichholzer; S Basaria; E Selvin; A S Dobs; N Kanarek; A Menke; W G Nelson; E A Platz
Journal:  Andrology       Date:  2014-03-20       Impact factor: 3.842

4.  Pattern of prostate cancer presentation among the Egyptian population: A study in a single tertiary care center.

Authors:  Ahmed Elabbady; Ahmed Eid; Ahmed Fahmy; Ahmed Fouad Kotb
Journal:  Cent European J Urol       Date:  2014-12-05

5.  Prostate cancer in the Arab population. An overview.

Authors:  Osman Z Al-Abdin; Ibrahim Z Al-Beeshi
Journal:  Saudi Med J       Date:  2018-05       Impact factor: 1.484

6.  Do evolutionary life-history trade-offs influence prostate cancer risk? a review of population variation in testosterone levels and prostate cancer disparities.

Authors:  Louis Calistro Alvarado
Journal:  Evol Appl       Date:  2012-12-11       Impact factor: 5.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.